Business Description
DOD Biotech PCL
ISIN : TH8569010003
Share Class Description:
BKK:DOD: Ordinary SharesCompare
Compare
Traded in other countries / regions
DOD.Thailand IPO Date
2018-06-20Description
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.7 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 1.36 | |||||
Interest Coverage | 2.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.47 | |||||
Beneish M-Score | -2.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.1 | |||||
3-Year Book Growth Rate | -0.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.81 | |||||
9-Day RSI | 34.8 | |||||
14-Day RSI | 32.86 | |||||
3-1 Month Momentum % | -8.67 | |||||
6-1 Month Momentum % | 4.64 | |||||
12-1 Month Momentum % | -24.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.28 | |||||
Quick Ratio | 2.45 | |||||
Cash Ratio | 0.97 | |||||
Days Inventory | 98.53 | |||||
Days Sales Outstanding | 33.06 | |||||
Days Payable | 65.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.24 | |||||
Dividend Payout Ratio | 1.32 | |||||
Forward Dividend Yield % | 4.24 | |||||
5-Year Yield-on-Cost % | 4.31 | |||||
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 7.09 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.82 | |||||
Operating Margin % | 1.65 | |||||
Net Margin % | 1.88 | |||||
EBITDA Margin % | 8.83 | |||||
FCF Margin % | -15.76 | |||||
OCF Margin % | -1.67 | |||||
ROE % | 1.12 | |||||
ROA % | 0.94 | |||||
ROIC % | 1.13 | |||||
3-Year ROIIC % | -9.62 | |||||
ROC (Joel Greenblatt) % | 0.9 | |||||
ROCE % | 0.56 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 59 | |||||
PE Ratio without NRI | 31.06 | |||||
Shiller PE Ratio | 8.35 | |||||
PS Ratio | 0.96 | |||||
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 0.59 | |||||
EV-to-EBIT | 86.35 | |||||
EV-to-EBITDA | 9.75 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-FCF | -5.36 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 0.9 | |||||
Price-to-Graham-Number | 0.9 | |||||
| Price-to-Net-Current-Asset-Value | 2.74 | |||||
Earnings Yield (Greenblatt) % | 1.16 | |||||
FCF Yield % | -16.53 | |||||
Forward Rate of Return (Yacktman) % | -9.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DOD Biotech PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 557.824 | ||
| EPS (TTM) (฿) | 0.02 | ||
| Beta | 1.531 | ||
| 3-Year Sharpe Ratio | -0.5 | ||
| 3-Year Sortino Ratio | -0.79 | ||
| Volatility % | 48.56 | ||
| 14-Day RSI | 32.86 | ||
| 14-Day ATR (฿) | 0.073662 | ||
| 20-Day SMA (฿) | 1.2815 | ||
| 12-1 Month Momentum % | -24.04 | ||
| 52-Week Range (฿) | 1.05 - 2.32 | ||
| Shares Outstanding (Mil) | 450.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DOD Biotech PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DOD Biotech PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.050000 Cash Dividend | 2026-03-13 | 1.79 (+2.87%) |
Show
Entries
DOD Biotech PCL Frequently Asked Questions
What is DOD Biotech PCL(BKK:DOD)'s stock price today?
The current price of BKK:DOD is ฿1.18. The 52 week high of BKK:DOD is ฿2.32 and 52 week low is ฿1.05.
When is next earnings date of DOD Biotech PCL(BKK:DOD)?
The next earnings date of DOD Biotech PCL(BKK:DOD) is .
Does DOD Biotech PCL(BKK:DOD) pay dividends? If so, how much?
The Dividend Yield %  of DOD Biotech PCL(BKK:DOD) is 4.24% (As of Today), Highest Dividend Payout Ratio of DOD Biotech PCL(BKK:DOD) was 1.32. The lowest was 0.48. And the median was 0.5. The  Forward Dividend Yield % of DOD Biotech PCL(BKK:DOD) is 4.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DOD Biotech PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers